Drug Type Small molecule drug |
Synonyms DX 9065A |
Target |
Action inhibitors |
Mechanism factor Xa inhibitors(Factor Xa inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H39ClN4O8 |
InChIKeyLJCBAPRMNYSDOP-LVCYMWGESA-N |
CAS Registry155204-81-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Coronary Syndrome | Phase 2 | United States | - | - |
| Acute Coronary Syndrome | Phase 2 | Japan | - | |
| Acute Coronary Syndrome | Phase 2 | Canada | - | - |
| Angina Pectoris | Phase 2 | - | - | |
| Coronary Restenosis | Phase 2 | United States | - | |
| Disseminated Intravascular Coagulation | Phase 2 | Japan | - | |
| Thrombosis | Phase 1 | United States | - | |
| Thrombosis | Phase 1 | Europe | - |





